Biocodex to present new data at the American Epilepsy Society (AES) 2024 Annual Meeting

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 12/02/2024.
  • Additional Information
    • Alternate Title:
      BIOCODEX-at-aes-meet
    • Subject Terms:
      New Jersey
    • Abstract:
      BEDMINSTER, N.J., Dec. 2, 2024 /PRNewswire/ -- Biocodex, a global pharmaceutical company and long-time pioneer in the treatment of rare pediatric diseases, will present seven studies at the upcoming AES 2024 Annual Meeting in Los Angeles, CA, from December 6-10. The studies focus on the use of stiripentol and its impact on patients with Dravet syndrome. [ABSTRACT FROM PUBLISHER]